EP243. 新藥開發門檻持續下降，CRO如何成為推手？為何在台灣爆發？ ft. 台灣安美睿營運長何佳樺

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.